Bruker Daltonics Reports Spike in Revenue, Rising Profits for Q1 2001 | GenomeWeb

NEW YORK, May 7 – Bruker Daltonics reported strong revenue growth for the first quarter of 2001, with revenue jumping to $21.7 million from $14 million in the comparable quarter a year ago.

The company classified 70 percent of its revenue from life science products, 8 percent from substance detection products, and 22 percent from aftermarket products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.